Crossmark

In vitro selection of macrocyclic peptide inhibitors containing cyclic γ2,4-amino acids targeting the SARS-CoV-2 main protease

Crossref DOI link: https://doi.org/10.1038/s41557-023-01205-1

Published Online: 2023-05-22

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Miura, Takashi https://orcid.org/0000-0002-1945-6070
Malla, Tika R. https://orcid.org/0000-0003-4989-6410
Owen, C. David

Tumber, Anthony

Brewitz, Lennart https://orcid.org/0000-0002-9465-777X
McDonough, Michael A. https://orcid.org/0000-0003-4664-6942
Salah, Eidarus

Terasaka, Naohiro https://orcid.org/0000-0002-4988-6899
Katoh, Takayuki https://orcid.org/0000-0001-6550-6203
Lukacik, Petra

Strain-Damerell, Claire

Mikolajek, Halina

Walsh, Martin A. https://orcid.org/0000-0001-5683-1151
Kawamura, Akane https://orcid.org/0000-0003-1169-5082
Schofield, Christopher J. https://orcid.org/0000-0002-0290-6565
Suga, Hiroaki https://orcid.org/0000-0002-5298-9186
License Information

Text and Data Mining valid from 2023-05-22

Version of Record valid from 2023-05-22
More Information

Article History

Received: 5 April 2022

Accepted: 14 April 2023

First Online: 22 May 2023

Competing interests

: The authors declare no competing interests.